Genesis Therapeutics, Inc. H1B salary
6 certified LCAs · FY2022–FY2025
- Certified filings
- 6
- Avg wage
- $216,719
- Median wage
- $232,658
- Active years
- FY2022–FY2025
Wage level distribution
Filings — last 8 quarters
Top H1B job titles at Genesis Therapeutics, Inc.
Recent certified records
| Job Title↕ | Wage (annual)↕ | Level | Location | FY/Q▼ | Status |
|---|---|---|---|---|---|
| Machine Learning Research Engineer | $215,716 | Level II | Burlingame, CA | Q3 FY2025 | Certified |
| AI Fellow | $249,600 | Level II | Burlingame, CA | Q2 FY2025 | Certified |
| Sr ML Research Scientist | $250,000 | Level II | Burlingame, CA | Q1 FY2025 | Certified |
| Senior Scientist | $145,000 | Level IV | San Diego, CA | Q3 FY2024 | Certified |
| Software Engineer | $165,000 | Level III | Burlingame, CA | Q3 FY2023 | Certified |
| Principal Research Scientist | $275,000 | Level IV | Burlingame, CA | Q3 FY2022 | Certified |
PERM green card filings
Unlock Genesis Therapeutics, Inc.'s PERM history
Sign in with a free account to see full PERM green card filing data — counts, roles, wages, and outcomes — for every company.
Sign in to unlockDoes Genesis Therapeutics, Inc. sponsor H1B?
›Does Genesis Therapeutics, Inc. sponsor H1B?
Based on 6 certified LCAs filed in FY2022–FY2025, Genesis Therapeutics, Inc. has an established history of H1B-related labor condition applications with DOL. An LCA is a labor condition application certified by DOL; it does not by itself constitute an approved H-1B petition or an employment offer, and past filings do not guarantee future sponsorship.
›What does Genesis Therapeutics, Inc. pay H1B workers?
Across certified LCA filings, Genesis Therapeutics, Inc.'s average offered wage is $216,719 (median $232,658). Actual pay varies by role, level, and work location — see the records below.
›Where does Genesis Therapeutics, Inc. file H1B LCAs?
The most frequent work location on record is Burlingame, CA (5 certified filings).
Related companies
Records shown are certified LCAs from DOL OFLC disclosure files for Genesis Therapeutics, Inc..